Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low- and middle-income countries: recommendations for a public health approach

World Health Organization.

The objective of this document is to provide technical recommendations on effective interventions for the prevention and treatment of HIV and other sexually transmitted infections (STIs) among sex workers and their clients. These include evidence-based recommendations following the GRADE methodology as w...

Trabajo Sexual, Infecciones por VIH, Enfermedades de Transmisión Sexual, Sexo Inseguro, Conducta Sexual, Parejas Sexuales, Países en Desarrollo

Texto completo (enlace principal) Texto completo (enlace alternativo) Texto completo (enlace alternativo)

WHO guideline on country pharmaceutical pricing policies

World Health Organization.

Medicines account for 20–60% of health spending in low- and middle-income countries, compared with 18% in countries of the Organisation for Economic Co-operation and Development. Up to 90% of the population in developing countries purchase medicines through out-of-pocket payments, making medicines the ...

Costos de los Medicamentos, Gastos en Salud, Formulación de Políticas, Países en Desarrollo, Economía Farmacéutica

Texto completo

Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

World Health Organization.

In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...

Tuberculosis/tratamiento farmacológico, Infecciones por VIH/complicaciones, Isoniazida/uso terapéutico, Valor Predictivo de las Pruebas, Países en Desarrollo

Texto completo